Characterization of Escherichia coli isolated from gut biopsies of newly diagnosed patients with inflammatory bowel disease

Inflammatory Bowel Diseases

Volumn 17, Issue 7, 2011, Pages 1451-1463

  Sepehri, Shadi ^a   Khafipour, Ehsan ^a   Bernstein, Charles N ^a   Coombes, Brian K ^b   Pilar, Ana V ^b   Karmali, Mohamed ^c   Ziebell, Kim ^c   Krause, Denis O ^a  

^a UNIVERSITY OF MANITOBA   (Canada)

^b MCMASTER UNIVERSITY   (Canada)

^c PUBLIC HEALTH AGENCY OF CANADA   (Canada)

Author keywords

Crohn's disease; inflammatory bowel disease; mucosal associated E. coli; ulcerative colitis; virulence characterization

Indexed keywords

CARRIER PROTEIN; SERINE PROTEASE AUTOTRANSPORTER; UNCLASSIFIED DRUG; VIRULENCE FACTOR;

ADULT; AFAE GENE; AMINO ACID SUBSTITUTION; ARTICLE; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIUM ISOLATE; BACTERIUM ISOLATION; CELL SURVIVAL; CGSA GENE; CNF GENE; COLON BIOPSY; CONTROLLED STUDY; CRL GENE; CROHN DISEASE; EAE GENE; ENTERITIS; ESCHERICHIA COLI; FIMBRIA; FIMH GENE; GENE SEQUENCE; HLYA GENE; HUMAN; HUMAN TISSUE; KPSMTII GENE; MACROPHAGE; MALX GENE; NONHUMAN; OMPA GENE; PATHOGENESIS; PHYLOGENY; PRIORITY JOURNAL; SEROTYPE; ULCERATIVE COLITIS; VT1 GENE; VT2 GENE;

ADULT; COLITIS, ULCERATIVE; CROHN DISEASE; DNA, BACTERIAL; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; HUMANS; INTESTINAL MUCOSA; POLYMERASE CHAIN REACTION;

EID: 79958799781     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1002/ibd.21509     Document Type: Article

References (53)

1. Thia, KT, Loftus, EV Jr, Sandborn, WJ, et al. An update on the epidemiology of inflammatory bowel disease in Asia. Am J Gastroenterol. 2008; 103: 3167-3182.
2. Tang LY, Nabalamba A, Graff LA, et al. A comparison of self-perceived health status in inflammatory bowel disease and irritable bowel syndrome patients from a Canadian national population survey. Can J Gastroenterol. 2008; 22: 475-483. (Pubitemid 351943676)
3. Packey CD, Sartor RB., Interplay of commensal and pathogenic bacteria, genetic mutations, and immunoregulatory defects in the pathogenesis of inflammatory bowel diseases. J Intern Med. 2008; 263: 597-606. (Pubitemid 351678591)
4. Sartor RB., Innate immunity in the pathogenesis and therapy of IBD. J Gastroenterol. 2003; 38 (suppl 15): 43-47. (Pubitemid 36442885)
5. Bibiloni R, Mangold M, Madsen KL, et al. The bacteriology of biopsies differs between newly diagnosed, untreated, Crohn's disease and ulcerative colitis patients. J Med Microbiol. 2006; 55: 1141-1149. (Pubitemid 44215574)
6. Sepehri S, Kotlowski R, Bernstein CN, et al. Microbial diversity of inflamed and noninflamed gut biopsy tissues in inflammatory bowel disease. Inflamm Bowel Dis. 2007; 13: 675-683. (Pubitemid 46909981)
7. Willing B, Halfvarson J, Dicksved J, et al. Twin studies reveal specific imbalances in the mucosa-associated microbiota of patients with ileal Crohn's disease. Inflamm Bowel Dis. 2009; 15: 653-660.
8. Man SM, Zhang L, Day AS, et al. Detection of enterohepatic and gastric Helicobacter species in fecal specimens of children with Crohn's disease. Helicobacter. 2008; 13: 234-238.
9. Zhang L, Man SM, Day AS, et al. Detection and isolation of Campylobacter species other than C. jejuni from children with Crohn's disease. J Clin Microbiol. 2009; 47: 453-455.
10. Jeyanathan M, Boutros-Tadros O, Radhi J, et al. Visualization of Mycobacterium avium in Crohn's tissue by oil-immersion microscopy. Microbes Infect. 2007; 9: 1567-1573. (Pubitemid 350217081)
11. Kotlowski R, Bernstein CN, Sepehri S, et al. High prevalence of Escherichia coli belonging to the B2+D phylogenetic group in inflammatory bowel disease. Gut. 2007; 56: 669-675. (Pubitemid 46662933)
12. Martinez-Medina M, Aldeguer X, Lopez-Siles M, et al. Molecular diversity of Escherichia coli in the human gut: new ecological evidence supporting the role of adherent-invasive E. coli (AIEC) in Crohn's disease. Inflamm Bowel Dis. 2009; 15: 872-882.
13. Eaves-Pyles T, Allen CA, Taormina J, et al. Escherichia coli isolated from a Crohn's disease patient adheres, invades, and induces inflammatory responses in polarized intestinal epithelial cells. Int J Med Microbiol. 2008; 298: 397-409. (Pubitemid 351734791)
14. Subramanian S, Roberts CL, Hart CA, et al. Replication of colonic Crohn's disease mucosal Escherichia coli isolates within macrophages and their susceptibility to antibiotics. Antimicrob Agents Chemother. 2008; 52: 427-434. (Pubitemid 351170809)
15. Simpson KW, Dogan B, Rishniw M, et al. Adherent and invasive Escherichia coli is associated with granulomatous colitis in boxer dogs. Infect Immun. 2006; 74: 4778-4792. (Pubitemid 44157265)
16. Dogan B, Klaessig S, Rishniw M, et al. Adherent and invasive Escherichia coli are associated with persistent bovine mastitis. Vet Microbiol. 2006; 116: 270-82. (Pubitemid 44223884)
17. Ewers C, Li G, Wilking H, et al. Avian pathogenic, uropathogenic, and newborn meningitis-causing Escherichia coli: how closely related are they ? Int J Med Microbiol. 2007; 297: 163-176. (Pubitemid 46678924)
18. Sheldon IM, Rycroft AN, Dogan B, et al. Specific strains of Escherichia coli are pathogenic for the endometrium of cattle and cause pelvic inflammatory disease in cattle and mice. PLoS One. 2010; 5: e9192.
19. Carvalho FA, Barnich N, Sauvanet P, et al. Crohn's disease-associated Escherichia coli LF82 aggravates colitis in injured mouse colon via signaling by flagellin. Inflamm Bowel Dis. 2008; 14: 1051-1060.
20. Barnich N, Carvalho FA, Glasser AL, et al. CEACAM6 acts as a receptor for adherent-invasive E. coli, supporting ileal mucosa colonization in Crohn disease. J Clin Invest. 2007; 117: 1566-1574. (Pubitemid 46871341)
21. Sepehri S, Kotlowski R, Bernstein CN, et al. Phylogenetic analysis of inflammatory bowl disease associated Escherichia coli and the FimH virulence determinant. Inflamm Bowel Dis. 2009; 15: 1737-1745.
22. Bronowski C, Smith SL, Yokota K, et al. A subset of mucosa-associated Escherichia coli isolates from patients with colon cancer, but not Crohn's disease, share pathogenicity islands with urinary pathogenic E. coli. Microbiology. 2008; 154: 571-583. (Pubitemid 351292311)
23. Baumgart M, Dogan B, Rishniw M, et al. Culture independent analysis of ileal mucosa reveals a selective increase in invasive Escherichia coli of novel phylogeny relative to depletion of Clostridiales in Crohn's disease involving the ileum. ISME J. 2007; 1: 403-418. (Pubitemid 47373247)
24. Tenaillon O, Skurnik D, Picard B, et al. The population genetics of commensal Escherichia coli. Nat Rev Microbiol. 2010; 8: 207-217.
25. Hill JE, Penny SL, Crowell KG, et al. cpnDB: a chaperonin sequence database. Genome Res. 2004; 14: 1669-1675. (Pubitemid 39193418)
26. Hill JE, Seipp RP, Betts M, et al. Extensive profiling of a complex microbial community by high-throughput sequencing. Appl Environ Microbiol. 2002; 68: 3055-3066. (Pubitemid 34602031)
27. Larkin MA, Blackshields G, Brown NP, et al. Clustal W and Clustal X version 2.0. Bioinformatics. 2007; 23: 2947-2948. (Pubitemid 350162903)
28. Cole JR, Wang Q, Cardenas E, et al. The Ribosomal Database Project: improved alignments and new tools for rRNA analysis. Nucleic Acids Res. 2009; 37: D141-145.
29. Martin HM, Campbell BJ, Hart CA, et al. Enhanced Escherichia coli adherence and invasion in Crohn's disease and colon cancer. Gastroenterology. 2004; 127: 80-93. (Pubitemid 38962277)
30. Machado J, Grimont F, Grimont PA., Identification of Escherichia coli flagellar types by restriction of the amplified fliC gene. Res Microbiol. 2000; 151: 535-546.
31. Maurer JJ, Brown TP, Steffens WL, et al. The occurrence of ambient temperature-regulated adhesins, curli, and the temperature-sensitive hemagglutinin tsh among avian Escherichia coli. Avian Dis. 1998; 42: 106-118. (Pubitemid 28159173)
32. Johnson JR, Stell AL., Extended virulence genotypes of Escherichia coli strains from patients with urosepsis in relation to phylogeny and host compromise. J Infect Dis. 2000; 181: 261-272. (Pubitemid 30049057)
33. Oteo J, Delgado-Iribarren A, Vega D, et al. Emergence of imipenem resistance in clinical Escherichia coli during therapy. Int J Antimicrob Agents. 2008; 32: 534-537.
34. Nakano M, Yamamoto S, Terai A, et al. Structural and sequence diversity of the pathogenicity island of uropathogenic Escherichia coli which encodes the USP protein. FEMS Microbiol Lett. 2001; 205: 71-76. (Pubitemid 33135441)
35. Conte MP, Schippa S, Zamboni I, et al. Gut-associated bacterial microbiota in paediatric patients with inflammatory bowel disease. Gut. 2006; 55: 1760-1767. (Pubitemid 44893575)
36. Barnich N, Darfeuille-Michaud A., Adherent-invasive Escherichia coli and Crohn's disease. Curr Opin Gastroenterol. 2007; 23: 16-20. (Pubitemid 44875904)
37. Darfeuille-Michaud A, Boudeau J, Bulois P, et al. High prevalence of adherent-invasive Escherichia coli associated with ileal mucosa in Crohn's disease. Gastroenterology. 2004; 127: 412-421. (Pubitemid 39091889)
38. Schippa S, Conte MP, Borrelli O, et al. Dominant genotypes in mucosa-associated Escherichia coli strains from pediatric patients with inflammatory bowel disease. Inflamm Bowel Dis. 2009; 15: 661-672.
39. Sasaki M, Sitaraman SV, Babbin BA, et al. Invasive Escherichia coli are a feature of Crohn's disease. Lab Invest. 2007; 87: 1042-1054. (Pubitemid 47429187)
40. Servin AL., Pathogenesis of Afa/Dr diffusely adhering Escherichia coli. Clin Microbiol Rev. 2005; 18: 264-292. (Pubitemid 40548294)
41. Henderson IR, Navarro-Garcia F, Desvaux M, et al. Type V protein secretion pathway: the autotransporter story. Microbiol Mol Biol Rev. 2004; 68: 692-744. (Pubitemid 39628534)
42. Danese PN, Pratt LA, Dove SL, et al. The outer membrane protein, antigen 43, mediates cell-to-cell interactions within Escherichia coli biofilms. Mol Microbiol. 2000; 37: 424-432. (Pubitemid 30481024)
43. Kjaergaard K, Schembri MA, Hasman H, et al. Antigen 43 from Escherichia coli induces inter- and intraspecies cell aggregation and changes in colony morphology of Pseudomonas fluorescens. J Bacteriol. 2000; 182: 4789-4796. (Pubitemid 30641800)
44. Kjaergaard K, Schembri MA, Ramos C, et al. Antigen 43 facilitates formation of multispecies biofilms. Environ Microbiol. 2000; 2: 695-702. (Pubitemid 33136684)
45. Hacker J, Kaper JB., Pathogenicity islands and the evolution of microbes. Annu Rev Microbiol. 2000; 54: 641-679.
46. Morschhauser J, Uhlin BE, Hacker J., Transcriptional analysis and regulation of the sfa determinant coding for S fimbriae of pathogenic Escherichia coli strains. Mol Gen Genet. 1993; 238: 97-105. (Pubitemid 23130639)
47. Smith SGJ, Mahon V, Lambert MA, et al. A molecular Swiss army knife: OmpA structure, function and expression. FEMS Microbiol Lett. 2007; 273: 1-11. (Pubitemid 47024891)
48. Sukumaran SK, Shimada H, Prasadarao NV., Entry and intracellular replication of Escherichia coli K1 in macrophages require expression of outer membrane protein A. Infect Immun. 2003; 71: 5951-5961. (Pubitemid 37205647)
49. Mow WS, Vasiliauskas EA, Lin YC, et al. Association of antibody responses to microbial antigens and complications of small bowel Crohn's disease. Gastroenterology. 2004; 126: 414-424. (Pubitemid 38182298)
50. Yamamoto S, Nakano M, Terai A, et al. The presence of the virulence island containing the usp gene in uropathogenic Escherichia coli is associated with urinary tract infection in an experimental mouse model. J Urol. 2001; 165: 1347-1351. (Pubitemid 32210288)
51. Johnson JR, Kuskowski MA, Gajewski A, et al. extended virulence genotypes and phylogenetic background of Escherichia coli isolates from patients with cystitis, pyelonephritis, or prostatitis. J Infect Dis. 2005; 191: 46-50. (Pubitemid 40041399)
52. Boudeau J, Barnich N, Darfeuille-Michaud A., Type 1 pili-mediated adherence of Escherichia coli strain LF82 isolated from Crohn's disease is involved in bacterial invasion of intestinal epithelial cells. Mol Microbiol. 2001; 39: 1272-1284. (Pubitemid 32225137)
53. Picard B, Garcia JS, Gouriou S, et al. The link between phylogeny and virulence in Escherichia coli extraintestinal infection. Infect Immun. 1999; 67: 546-553. (Pubitemid 29059185)